Fig. 4From: Minocycline prevents and repairs the skin disorder associated with afatinib, one of the epidermal growth factor receptor-tyrosine kinase inhibitors for non-small cell lung cancerHistological examination by HE staining. a pretreatment control with vehicle (:WP), b pretreatment with minocycline WP, c control treatment with vehicle (:WP) after appearance of rash, and d minocycline WP treatment after appearance of rashBack to article page